Calgary's Seegnal Inc. Welcomes New CEO, Bolstering City's Tech Ambitions
A New Era for Seegnal
Calgary-based Seegnal Inc. (TSXV: SEGN), a leader in clinical decision support, has announced the appointment of Elad Bibi-Aviv as its new Chief Executive Officer, effective December 16, 2025. This strategic leadership change arrives as Calgary continues to aggressively position itself as Canada's innovation capital, a vision outlined in the city's 2025 Innovation Strategy.
Visionary Leadership for Global Impact
Mr. Bibi-Aviv brings a robust track record, having co-founded and led Israeli insurtech Covary to over 10,000 customers before its acquisition. He then served as COO of AI-driven health-tech provider NeuroKaire. His expertise in AI and scaling health-tech solutions perfectly aligns with Seegnal’s mission. Outgoing CEO Eyal Schneid will transition to General Manager of Seegnal E-Health Ltd., the company’s Israeli operating subsidiary.
Advancing Health Tech in Calgary and Beyond
Seegnal's SaaS-based platform is already making significant strides; it's a 'standard of care' for over 10,000 clinicians in Israel, with the Israeli Ministry of Health planning nationwide deployment of its patient-specific standard by 2025. The company markets its innovative solution across Israel, the UAE, UK, US, and Poland. Seegnal's growth exemplifies Calgary's burgeoning tech ecosystem, which saw an $8.1 billion value increase between 2021-2023. This aligns with provincial support for digital health and AI, reinforcing Alberta's goal to become a leading North American AI hub.
